Characteristics |
|
Age (year) |
|
Median (range) |
46 (22-70) |
Type of disease, n (%) |
|
Ovarian cancer |
50 (96.2) |
Tubal cancer |
1 (1.9) |
Primary peritoneal cancer |
1 (1.9) |
Stage (FIGO, 1989), n (%) |
|
Ia |
16 (30.8) |
Ib |
2 (3.8) |
Ic |
19 (36.5) |
IIa |
3 (5.8) |
IIb |
7 (13.5) |
IIc |
5 (9.6) |
Histology, n (%) |
|
Serous |
12 (23.1) |
Mucinous |
9 (17.3) |
Endometrioid |
11 (21.2) |
Clear cell |
14 (26.9) |
Transitional cell |
2 (3.8) |
Mixed |
4 (7.7) |
Grade, n (%) |
|
I |
12 (23.1) |
II |
18 (34.6) |
III |
13 (25.0) |
Unknown |
9 (17.3) |
CA-125 (U/mL)*
|
|
Median (range) |
43 (8-4389) |
>35, n (%) |
27 (54) |
Co-existence of Endometriosis, n (%) |
|
Yes |
15 (28.8) |
Adnexa |
6 (11.5) |
Rectum |
4 (7.7) |
Adnexa + Rectum |
1 (1.9) |
Adnexa + PCDS |
1 (1.9) |
Peritoneum |
3 (5.8) |
No |
37 (71.2) |